GS1_Healthcare_Reference_Book_20092010_1
GS1_Healthcare_Reference_Book_20092010_1
GS1 Standards in healthcare: raising the bar on patient safety and supply chain efficiency. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
U.S.A.: Change has finally come: U.S. Healthcare industry to implement common data standards
to improve safety, reduce costs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
P. R. China: Shanghai Food and Drug Administration – Implementation of a post-market traceability program
for implantable medical devices adopting unique device identification. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
U.K.: The NHS Procurement eEnablement Programme – Using information to deliver better healthcare. . . . . . . . . . . . . . . . . . . . . 22
U.K.: Integrating information flows in orthopaedics at Leeds Teaching Hospitals NHS Trust. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Japan: rfid and barcode based management of surgical instruments in a theatre sterile supply unit. . . . . . . . . . . . . . . . . . . . . . . 32
Australia: eCommerce within the hospital pharmaceutical supply chain lays foundation for improved patient safety. . . . . . . . 40
Canada: Transforming the Canadian healthcare supply chain: creating the future roadmap for success. . . . . . . . . . . . . . . . . . . . . . 48
Acknowledgements
GS1 Healthcare would like to thank the following for contributing to this GS1 Healthcare Reference Book:
• Nigel Allsop (Health Purchasing Victoria, Australia)
• Alexandra Fabreguettes (Robert Ballanger Hospital, Aulnay, France)
• Frédérique Frémont (Robert Ballanger Hospital, Aulnay, France)
• Jesus Gavira (SAS Andalusian Health Service, Spain)
• Ged Halstead (CH2, Australia)
• Yasmine Hassani (Robert Ballanger Hospital, Aulnay, France)
• Noel Hodges (HCA Central Atlantic Supply Chain, U.S.A.)
• Rachel Hodson-Gibbons (NHS Purchasing and Supply Agency, U.K.)
• Anthony Keyes (Baxter Healthcare, Australia & New Zealand)
• Holger Klein (Herz-Zentrum Bad Krozingen, Germany)
• Ian Larmour (Southern Health group of hospitals in Melbourne, Australia)
• Herb Martin (CareNET, Canada)
• Laurent Médioni (Fribourg Canton Pharmacy, Switzerland)
• Graham Medwell (Leeds Teaching Hospitals NHS Trust, U.K.)
• Jeanne Mignon (Robert Ballanger Hospital, Aulnay, France)
• Georges Nicolaos (Robert Ballanger Hospital, Aulnay, France)
• Dr. Chikayuki Ochiai (Kanto Medical Center NTT, Tokyo, Japan)
• Joe Pleasant (Premier, Inc., U.S.A.)
• Marine Tournoud (Robert Ballanger Hospital, Aulnay, France)
• Liang Yan (Shanghai Food and Drug Administration, China)
In addition, we would like to thank the following GS1 Member Organisations for facilitating this process:
• GS1 Australia (contact: Tania Snioch - [email protected])
• GS1 Canada (contact: Alicia Duval - [email protected])
• GS1 China (contact: Zexia Huang - [email protected])
• GS1 France (contact : Valérie Marchand - [email protected])
• GS1 Germany (contact: Bettina Bartz - [email protected])
• GS1 Japan (contacts : Michio Hamano - [email protected] and Yasuo Kurosawa - [email protected])
• GS1 Spain (contact: Mónica Soler - [email protected])
• GS1 Switzerland (contact: Christian Hay - [email protected])
• GS1 UK (contact: Roger Lamb - [email protected])
• GS1 US (contacts: Dennis Harrison – [email protected] and Annette Pomponio - [email protected])
Abstract
Challenges and opportunities in the multi-echelon global supply chains that currently lack
healthcare supply chain transparency, making it vulnerable to infiltration by
Patient safety initiatives across the world tackle the counterfeiters. The introduction of a unique identification
challenges in the Healthcare supply chain, including for each and every pack, where appropriate, will enable
the reduction of medication errors, the fight against traceability and authentication systems with readily available
counterfeiting, optimised post-market surveillance, etc. technology. This will make it much more difficult for
counterfeiters to intrude into the Healthcare supply chain, or
More than 30% of all adverse drug events are preventable at least, make it uneconomic.
and appear to be consequences of medication errors1.
Adverse events from medication errors represent a significant Other patient safety initiatives are related to improving post-
problem for Healthcare worldwide, as indicated by several market surveillance and adverse event reporting, product
studies in different countries. An Adverse Event Study in recalls, disaster preparation, treatment documentation, etc.
one country indicated that 9.3% of hospital stays incurred
a serious adverse event, with medication errors being the Reducing costs and increasing supply chain efficiency
main cause (37.4% of such events)2. The implementation of will contribute to keeping soaring Healthcare costs under
automatic identification systems, up to the point-of-care, has control. Diverging country requirements for supply chain
proven to significantly reduce medication errors; for example, data further complicate an already complex production,
the Veterans Affairs Medical Center in Topeka, U.S.A., has packaging and distribution system and add risk and cost.
reported that bar coding reduced its medication error rate by Manual systems and processes in hospitals are unable
86% over a nine-year period3. to efficiently and safely handle the constant change that
occurs with supplies and pharmaceuticals. Standardised
Counterfeit Healthcare products are in the first place a automatic identification and traceability systems will
risk to public health. It is almost impossible for patients simplify and improve accuracy in a number of supply chain
and dispensing Healthcare professionals to spot the processes from production to point-of-care or point-of-sale.
fakes. Healthcare products are supplied through complex,
GS1 Identification Keys can then be carried on any type of A voluntary, global Healthcare user group
data carrier, a GS1 bar code (linear or 2-dimensional) or an GS1 Healthcare is a voluntary, global Healthcare user group
EPCglobal Radio Frequency Identification (RFID) tag, on the bringing together all related Healthcare stakeholders.
specific product or packaging. Members range from leading pharmaceutical and medical
device manufacturers, healthcare providers, distributors and
The GS1 Global Data Synchronisation Network (GDSN), built Group Purchasing Organisations (GPOs), governmental and
around the Global Registry and GDSN-certified data pools, regulatory bodies and associations including the U.S. FDA,
provides a powerful environment for secure and continuous Public Health Agency Canada and Eucomed.
synchronisation of accurate product and location data.
The mission of GS1 Healthcare is to bring together experts Some notable examples are:
in Healthcare to develop and implement global standards
to successfully enhance patient safety and supply chain In the U.S.A.
efficiencies. • AHRMM, a professional membership group of the
American Hospital Association serving more than 4,000
GS1 Healthcare is now widely recognised as an open and active members
neutral source for regulatory agencies, trade organisations • Amerinet, a GPO serving more than 2,200 acute care and
and other similar stakeholders who are seeking input and 25,000 alternate care health systems members
direction for global standards in Healthcare for patient • Novation, a GPO serving 2,500 members of VHA Inc.
safety, supply chain security and efficiency, traceability and and the University HealthSystem Consortium (UHC) and
accurate data synchronisation. nearly 12,000 members of Provista, LLC
• Premier Inc., a GPO serving more than 2,000 hospitals
Healthcare suppliers advance global and 53,000-plus other healthcare sites
supply chain standards • SMI (Strategic Marketplace Initiative): 32 healthcare
Confronted with diverging country specific product provider members, including for example Duke
identification requirements and developing traceability University Health System, Johns Hopkins Health System,
requirements, suppliers were instrumental in establishing Mayo Clinic, Sisters of Mercy ~ ROi, SSM Health Care,
the global Healthcare user group in 2004-2005. Many University Kentucky HealthCare, and Yale New Haven
leading suppliers are members of the global Healthcare user Health System
group and actively drive global standards development and In Austria
adoption at a global level. • Orthopädisches Spital Speising GmbH, Vienna (Vinzenz
Gruppe) and Wiener Krankenanstaltenverbund are
At a global level, current supplier members include (dd. members of the global Healthcare user group
April 2009); Abbott, Alcon, Amgen, Baxter, B. Braun, Boston In Canada
Scientific, Bristol-Myers Squibb, Cook, Covidien, Edwards • CareNET, a not-for-profit organisation comprised of over
Lifesciences, Fresenius Kabi AG, GlaxoSmithKline, Johnson 450 hospitals across Canada
& Johnson, King Pharmaceutical, Medtronic, Merck & Co., • HealthPro, a GPO serving 485 hospitals
Novartis Pharma, Pall Medical, Pfizer, Purdue Pharma, Sakura • MedBuy, a GPO serving more than 350 Healthcare
Seiki, Schering-Plough, and Smiths Medical. facilities
In Chile
At a national level, many more suppliers are member of • Cenabast, the Supply Center for the Ministry of Health in
a GS1 Member Organisation and are involved in national Chile
initiatives to drive adoption and implementation of GS1 In France
Standards in the Healthcare supply chain. • UNIHA, a network of 32 university hospitals and 22 large
hospitals
Also other stakeholders, such as distributors, retailers, and In Germany
logistics providers have been involved. Global members • Comparatio Health, a GPO comprised of 6 university
include; CVS, Cardinal Health, DHL Exel Supply Chain, and hospitals
McKesson. • EK UNICO, a GPO comprised of 13 university hospitals,
including 300 special clinics and more than 240
Healthcare providers advance global institutes
supply chain standards In Hong Kong
Leading Healthcare providers and Group Purchasing • Hong Kong Hospital Authority, a statutory body
Organisations (GPOs) worldwide are endorsing GS1 managing 40 public hospitals, 48 specialist clinics and 75
Standards and are paving the way for sector-wide adoption. general clinics
In Japan
• Tokyo Medical University, Kanto Medical Center and
Nagoya University Hospital, etc.
• Providing input to the European Commission for the GS1 Healthcare will continue to promote global supply
legislative proposals to ensure safe, innovative, and chain standards and invites all stakeholders to join the user
accessible medicines currently being developed group, either at national or global level.
References
1 “Creation of a better medication safety culture in Europe: Building up safe medication practices” – Expert Group on Safe Medication Practices,
Council of Europe – 2007
2 Estudio Nacional sobre los efectos adversos ligados a la hospitalización (ENEAS 2005). Informe. Febrero 2006. Ministerio de Sanidad y
Consumo. Madrid 2006
3 “Strategies to Reduce Medication Errors - How the FDA is working to improve medication safety and what you can do to help”,
Michelle Meadows, FDA Consumer magazine May-June 2003
Authors
Ulrike Kreysa is Director Healthcare, GS1 Global Office Jan Denecker is Marketing Manager Healthcare & GDSN,
([email protected]) GS1 Global Office ([email protected])
Abstract
After decades of studies, pilots and colorful debate, the Healthcare’s most basic data – electronic descriptions of
healthcare industry is finally making huge strides toward the the products used to treat patients, which companies
selection and implementation of a consistent set of supply manufacture these products and where the products should
chain data standards and a system to synchronize product be delivered – is unreliable, inconsistent and out of date. Bad
information so that all trading partners can speak the same data has long served as the source of a negative ripple effect
electronic language. These standards, by GS1, have been throughout the supply chain that adds billions of dollars
proven successful in other multi-billion dollar industries. in avoidable costs, creates inefficient processes and, most
They are being endorsed by healthcare’s leading provider importantly, negatively impacts patient safety.
organizations, including the Premier healthcare alliance, as a
means to ensure basic information in the healthcare supply Other multibillion dollar industries, including grocery,
chain is accurate, up to date and synchronized. Premier and hardware and retail, run their supply chains more effectively.
others have taken steps to accelerate the implementation of What is their secret? These industries identify products
the GS1 standards in order to bring about greater efficiencies, using consistent electronic data standards, synchronized
reduce costs and improve the quality of patient care. through a single source of accurate product information, to
bring data truth to every part of the supply chain.
Healthcare’s Dirty Data
In 2008, healthcare spending in the United States reached Unlike virtually every other product in commerce, medical
$2.4 trillion, representing a staggering 17 percent of the supplies and devices cannot be identified in a systematic
nation’s gross domestic product. Medical supplies – a and consistent manner, and the healthcare industry is not
$200 billion industry – typically account for up to 40% of a able to reliably identify potentially life-threatening recalled
hospital’s operating costs, and represent the second largest or defective medical devices. Whereas other industries
expense to hospitals after labor. Industry estimates point to use consistent and synchronized data standards to ensure
more than $11 billion of waste each year due to inefficient all trading partners and information systems speak the
processes, rework, order and invoice errors and outdated same electronic language, healthcare lags in the ability,
information technology. At the core of these problems is for example, to track and trace a recalled product from
bad supply chain data. manufacturer to end use, or the patient’s bed side.
accelerate implementation of the standards that are needed patient may have used. These standards will contribute to
to improve patient safety, reduce costs and drive efficiency interoperability in healthcare, and will streamline the flow of
(see timeline and roadmap graphics). Due to our purchasing information in the supply chain and beyond.
power, organizations like Premier can play a significant
role in the acceleration of standards implementation, a With these standards serving as a basic foundation,
responsibility that we take seriously. hospitals and suppliers will be better able to automate
the data capture process via RFID and bar coding. The
It is anticipated that the U.S. Food and Drug Administration current challenges inherent in healthcare’s e-commerce
will issue its requirement to manufacturers to use a uniform transactions – varying levels of system sophistication,
system that recognizes the GS1 standards, a system that outdated IT, manual data inputting, inaccurate information
has proven itself in other industries and around the world. – will be a distant memory, making room for more effective
In addition, healthcare manufacturers are already using GS1 methods and providing a baseline for electronic records
standards to support their other markets here and abroad. management. With everyone in the supply chain “speaking
the same electronic language,” products can be better
This initiative, which will impact hundreds of thousands tracked and traced throughout, improving healthcare’s
of medical devices and supplies, complements and chaotic recall process and reducing the potential for the
strengthens the FDA’s work to create a uniform and introduction of counterfeits. Increasing efficiency will
nationwide system and will accelerate adoption by the reduce costs and positively impact patient safety – the
industry as a whole. Collaborating with suppliers on mission shared by all constituents of undeniably the nation’s
standards adoption will help ensure correct products are most important supply chain.
delivered to correct locations, leading to an increase in
patient safety, and a decrease in supply chain costs. The U.S. healthcare industry is pursuing the extraordinary
opportunity to leverage technology advances to create
The GS1 standards – the GTIN, GLN and GDSN® – are used a more efficient supply chain, reduce costs and, most
by Wal-Mart and other large retailers, and support the importantly, to improve the safety of patients that use
supply chains of the hardware, electrical and consumer medical products as part of their care. The question has
goods industries among others. They are tried and true in evolved from “if” to “when” the industry will reap the benefits
those industries, with results showing that clear visibility of adopting and implementing consistent supply chain data
to product information by both suppliers and buyers leads standards, and that time has come.
to more efficient business processes, reduced costs and
increased revenues. Everyone has something to gain. The GS1 standards required
Studies in healthcare show the same promising results, with in Premier contracts include:
the added benefit of increased patient safety. • Global Trade Item Number® (GTIN®) – A GS1 standard used
to uniquely identify products at all packaging levels, such
In healthcare, the three GS1 standards will help as medical devices, ranging from syringes to pacemakers,
electronically describe important information needed to reducing transaction errors and inefficiencies.
effectively move and track a product throughout the supply • Global Location Number (GLN) – A GS1 standard used
chain. They will also help communicate that information to uniquely identify locations and legal entities from
between different information systems within a hospital, or manufacturers, distributors, hospitals, all the way down
between a hospital and supplier, at any point in the supply to nursing stations. Reducing transaction errors while
chain and in any direction. ensuring that the right product, procedure, and/or
treatment is delivered to the right location.
Back to Basics • Global Data Synchronization Network® (GDSN®) – Stores
Basic information technology elements must come into GLNs, GTINs and associated product definitions or
play in healthcare in order to make a real difference on how attributes, allowing users to access accurate product
efficient the industry can become. It is not enough, for information including changes and updates. The GDSN is
example, to create an EHR when, right now, that EHR may used by more than 18,000 companies for more than three
not have the accurate information about which products a million products.
(e-Records, e-Prescriptions)
Automatic Data Capture
(EDI/XML Transactions)
(e-Pedigree, Recalls)
Equipment Tracking
100% GLN Adoption Timeline
e-Commerce
Traceability
Assets & 80%
f
no
sio ms
i n clu Ter
’s
60% Members by ier
ed em s
ort Pr ent
u pp ithin eem
S r
on ts w Ag
pti en ns
40% Ado irem ditio
N u n
GL N req & Co
GL
Author
Joe Pleasant is chief information officer and senior vice presi- improve healthcare quality and affordability. Premier maintains
dent of the Premier healthcare alliance. In his role, the nation’s most comprehensive repository of clinical,
Mr. Pleasant oversees Premier’s information systems infrastructure financial and outcomes information and operates a leading
that includes legacy, enterprise and Web-enabled offerings. Pre- healthcare purchasing network. A world leader in helping
mier participates in the DoD’s ongoing pilot testing the GDSN as deliver measurable improvements in care, Premier works with
a potential industry product data utility, and serves on the Board the Centers for Medicare & Medicaid Services and the United
of Governors for GS1 US. Kingdom’s National Health Service North West to improve
The Premier healthcare alliance is more than 2,100 U.S. hospitals hospital performance. Premier has offices in San Diego, Charlotte,
and 54,000-plus other healthcare sites working together to N.C., Philadelphia and Washington.
Abstract
Introduction that the actual effect of these legal measures fell short of
Implantable Medical Devices (IMD) pose the highest expectations. The following three major aspects have caused
potential risk among medical devices, so they are subject traceability problems:
to the most stringent management in the medical device • Firstly, basic IMD use information recorded during the
regulatory system of each country, regardless of pre-market process was inaccurate.
approval or post-market surveillance. Due to the high risk • Secondly, manufacturers could hardly collect the actual
and high profit, such products can cause other disorderly use data from the hospital, so they could not fulfil their
management problems in their sales, purchase, pricing and legal post-market responsibilities.
service links, and even lead to injuries or doctor-patient • Thirdly, the information of IMD use was not transparent,
disputes, so they raise serious concerns by the general which could not safeguard patients’ safety, rights and
public and the regulatory authorities. Shanghai began interests.
adopting Unique Device Identification (UDI) using GS1
Standards in 2007, and it was the first in China to set up a The most practical and effective means to address the
tracking system that links IMDs directly to patients. post-market traceability of these high risk medical devices is
to make use of current computer/IT technology and allow
Computerisation is an effective pathway to different legal entities to easily share IMD use data under
address post-market tracking the existing legal framework. The key to setting up such
Shanghai began to take legal supervisory measures on IMDs computerised tracking system is to establish a standards-
as of 2002, and a follow-up study after three years showed based UDI, to determine the traceability management mode,
and to set up a feasible tracking system.
Standards for IMD identification product name, specification and packing level. The
To establish a UDI system for IMD’s, it was necessary secondary barcodes are used to indicate key information
to understand the basic requirements of its use, then of the product, including product’s lot/batch number,
determine the UDI coding rules, and finally determine the and key dates, i.e. expiration date or manufacturing date;
scope of traceability information.
Key traceability information
Basic use requirements: in the IMD traceability system
1) UDI should be applied to any possible place of use; The information provided in the IMD traceability system
2) UDI should be able to remain independent from the needs to enable the effective handling of adverse events
above place of use; after their occurrence, such as product recall and patient
3) UDI should meet the compatibility requirements of identification.
current automatic reading technology environments
and should be adaptable to current legal environments; Accurately recording the UDI and patient ID is the
4) UDI should be based on a design structure with clear most important link
validation records and good stability and reliability; To track the adverse event related to IMDs, regulators need
5) UDI should have good technological expandability and the following basic information:
be able to accommodate various data media; 1) Basic information on product’s use;
6) UDI should meet the requirement for simple operations, 2) Information on the specific product involved in the
without multiple conversions during its use; adverse event;
7) The symbols making up the UDI should be easy to use; 3) Range of products that may have the same quality
8) UDI should be able to adapt to potential changes problem;
that may occur in the production and management 4) Patients involved in the product in question;
environments; 5) Location of the product(s) in question that have not yet
9) UDI should be affordable for organisations to implement been used.
and the benefits should outweigh the burdens;
10) UDI should comply with the operating rules of other Simply speaking, when we deal with an adverse event, we
regulations prevailing in the international market, such should use the UDI information of the product involved in
as the World Trade Organisation (WTO) rules. the adverse event and identify the patients involved; then
exercise control over the product held in inventory and
Shanghai UDI rules for IMD’s bring the potential injuries under effective control in the
1) Using linear barcodes. The technical environment for earliest possible time.
overall implementation of 2D barcodes and RFID is not
yet mature, and in order to meet the current urgent To enable tracing to the patients, it is critical to record the
need of tracking high risk medical device adverse events, UDI and patient identification (PID) at the time of use, and
we started from linear barcodes, and will then gradually keep all the information in the quality system of the supplier
develop into 2D barcodes and RFID; and the hospital. Shanghai stipulates that upon completion
2) Using the GS1 or HIBC coding standards. To allow every of any IMDs surgical operation, the automatic identification
supplier to quickly implement the UDI system in the of a UDI and recording of all relevant data of the patient
start-up phase, suppliers were allowed to choose either shall be completed and linked outside the operation room
GS1 or HIBC barcodes. This rule may be changed later of the hospital.
in the nationwide implementation of the UDI tracking
system to simplify the technical system. (For reference: Minimum traceability information
medical products that do not need to be traced can To trace an IMD to a patient, the UDI needs to be associated
directly adopt the GS1 EAN13 barcode as used in the with the following supporting information: product
Chinese supermarkets); name, model, specification, lot number or serial number,
3) Using primary and secondary barcodes; the primary registration certificate number, expiration date of the
barcodes are used to identify products and contain registration certificate, manufacturer’s name, name of the
information on the country of origin, manufacturer, after-sales service company of the imported product, and
Information on product pricing can be included for Manufacturers collects Hospital reports use
use data from FDA data to FDA surveillance
additional purposes. But for a system that needs to run surveillance platform platform
for a long period of time and to gather information on a
continuous basis, the principle of “the least information, The outside of the triangle as shown in Fig. 1 is the basic
the cost-effective” shall be followed in setting basic sales channel of IMDs where manufacturers sell their
management information requirements. products to hospitals directly or through a distributing chain
and final distributors.
Implementation of the IMD traceability
system in Shanghai Inside the above triangle is a data reporting platform
Shanghai started to implement the IMD traceability system administered by the Shanghai FDA/health authorities.
in November 2006 according to the above architecture and Hospitals report data relevant to the use of IMDs to this
management principles. The tracking system covers more platform, and through which, manufacturers / distributors
than 100 hospitals using IMDs in Shanghai, and the IMDs can retrieve information about the use of their products.
included high-risk devices such as orthopaedic internal This addresses the problem encountered by regulatory
fixation devices, orthopaedic implants, synthetic crystals, authorities that manufacturers can hardly obtain data
breast implants, pacemakers, heart valves, stents and relevant to the use of their IMDs from hospitals.
catheters. By June 2008, and through manual and automatic
online reporting, the data reporting platform of the tracking If an IMD manufacturer doubts the data available on the
system has gathered more than 175,000 entries of use data. reporting platform and refuses to recognize such data,
Data analysis showed that the tracking system plays a crucial the post-operation safety of patients using such IMD can
role in addressing the post-market surveillance of those hardly be assured, so the government will discover it and
high-risk medical devices, preventing the occurrence of supervision should step in as soon as possible.
injury events, and managing such events.
Implementation scheme
Triangular sales and supervisory model for IMDs The middle part in the schematic diagram of the tracking
Shanghai developed a triangular sales and supervisory system in Fig. 2 is consistent with the triangular sales model
model in the exploitation of IMDs. Theoretically speaking, it described in Fig. 1. Enterprises sell their products to hospitals
is the most simplified traceability management model directly or through a sales chain.
(See Fig. 1).
Upon completion of a surgical operation, the hospital
records the UDI using automatic identification technologies.
The product information will be reported together with the
patient information, collected from the Hospital Information
System (HIS) to the Shanghai FDA health data reporting
platform. At the same time, the information is linked to the
Identify data
Sales reporting
linked to
finance
Manufacturer
Hospital finance
Surgical records
Hospital data
Entrusted sales chain
hospital’s financial management system to manage financial 2) Entrusted by IMD manufacturers, the IMD distributors
records. The manufacturer can obtain hospital use data via shall be responsible for providing the traceability
the reporting platform. information on the IMDs, and take their own initiatives to
assist manufacturers in handling those potential adverse
To support hospitals in automatically reading the UDI, a events. IMD distributors shall not make UDI’s without
product data exchange platform is set up in the tracking prior authorization of manufacturers. UDI making must
system. Manufacturers can submit their product data to be authorized by and the entire process must be under
the hospital’s database, and can control distributors and the control of the manufacturer’s quality system.
hospitals directly and define the scope of the products sold 3) Hospitals shall establish automatic identification
to and used in the hospitals. management, registration and reporting system for UDI’s
of IMD’s, and keep the use records of such patients.
Legal responsibilities of each 4) Patients shall obtain relevant information of the IMDs.
responsible party Hospitals and manufacturers shall take their own
In post-market management, the depth of government initiatives to provide such information.
surveillance in the tracking system should be different as 5) In order to safeguard the interests of the public, the
risks related to products and treatments are different. Each government shall assume the supervisory and regulatory
party in the tracking system shall undertake the following responsibilities in the tracking system.
responsibilities:
In the tracking system, manufactures are required to meet
1) IMD manufacturers (or the domestic legal after-sales the UDI requirements in labelling their product, and medical
service institutions of imported products designated institutions to implement automatic UDI and recording
by manufacturers) shall be fully responsible for the system. These are the core links to ensure successful product
quality of their products after market release, for the traceability.
management and implementation of UDI marking,
tracking, recall of their products and handling of patient
injuries in adverse events, and for gathering and keeping
the use data through the health data reporting platform.
Author
Liang Yan is the head of Regulatory Affairs Division, and the served as head of the Science and Technology Department
International Cooperation Division and the former Head of of the Shanghai Pharmaceutical Administration Bureau, for
the Medical Device Registration Division of the Shanghai Food Shanghai’s pharmaceutical and medical devices industry research
and Drug Administration. Mr. Yan has more than 30 years and development of new technology and products. In 1989,
working experience in the medical-related administration of he organized a group for drafting China’s first medical devices
the Shanghai Municipal Government. Before the beginning regulations. Afterwards, he continued to work with the drafting
of the Chinese Reformation, he was engaged in innovation and implementation of China Medical Devices Regulation
and development of medical devices technology in Shanghai in Classification Rules, Medical Devices Registration, Medical
Medical Industry Co (SMIC). After the Chinese Reformation he Devices Recall area.
Abstract
CH2 follows Australia’s Therapeutic Goods Administration Along with other areas of focus, this has meant potentially
guideline, Uniform Recall Procedure for Therapeutic Goods1, extending the concept of a trade item to ‘unit of use’, which
when taking recall action. In the event of a recall the is the level of trade item dispensed to the patient in a
following procedure is adhered to: hospital environment.
• A manual check of CH2 branches is undertaken to
determine which sites have affected stock. CH2 is also working with GS1 to help engage their suppliers
• All affected stock on hand is quarantined ensuring to implement, where possible, GS1 Global Trade Item
further supply to customers is prevented. Numbers (GTINs) for product identification, Global Location
• A report indicating customers who have purchased Numbers (GLNs) as primary delivery/pricing records and
the product over a nominated period is sent to key Serial Shipping Container Codes (SSCCs) for tracking logistic
personnel at CH2. unit movement (warehousing and distribution).
• The relevant customers are notified and are required to
take their own action to collect any stock in question. Supplier Engagement – eMessaging
• The return and replacement of the recalled product is In 2007 none of CH2’s 900-plus suppliers were undertaking
subject to the procedure set out by the manufacturer. electronic messaging with our organisation. As the first
step in their supply-chain transformation, CH2 initiated
Currently, the processes for supply of medical and eMessaging (using GS1’s EANCOM purchase order,
pharmaceutical products in Australia are mainly manual purchase order response) with seven suppliers, using GTINs
and this has led to concerns that both suppliers and their as the primary item identifier and GLNs as the primary
customers can not easily identify and locate products in location identifier. Within two months of eCommerce
the case of a recall. Such concerns have prompted CH2 to implementation 100 per cent data accuracy rates were
initiate a 10-year plan working with suppliers and customers achieved in the messages exchanged, and much of this was
to ensure that supply chain integrity is achieved. due to the GTIN being used as the unique product identifier.
Right now there is no easy way for many of our customers The use of the GTIN has provided another notable benefit as
to locate products in the case of a recall without employees CH2 and its partners are now starting to overcome an issue
going into each and every ward, or hospital pharmacy or op- that continues to plague the healthcare sector- differing
erating suite and physically checking if the product is there. Units of Measure.
This leaves room for error and when you are dealing with
potential risk to human life, there can be no margin for error. This is having a flow-on effect throughout the CH2 Supply
Chain and has put our company in a stronger position to
In Australia we do not have a mandate for suppliers to use achieve Delivered In-Full, On-Time to Quality (DIFOTQ) with
the GS1 System for product identification. This is a voluntary our customers – a key objective for 2009. This is consistent
system and CH2 are urging companies to adopt the GS1 with our goal of having the right product in the right place
System so we can ultimately improve patient safety. at the right time.
Working with GS1 Australia The company continues to progress, aiming for all suppliers
To help drive this 10 year plan, CH2 has been actively to be trading via electronic messaging, including providing
working with GS1 Australia. CH2 is the chair of the GS1 Despatch Advices with lot and expiry dates as well as
Healthcare User Group (HUG) Australasia, the local chapter SSCC labels. If this goal is achieved, CH2 estimates a 45%
of GS1 Healthcare (the GS1 global healthcare user group). reduction in receiving time.
HUG Australasia is one of several such groups around the
world reviewing, developing and refining the GS1 System to Warehouse efficiency
ensure it is applicable for all aspects of the global healthcare CH2 had identified that our warehouse processes were
sector while remaining relevant to other industry sectors. hampered by the inability to easily track goods. As the next
logical step in our supply chain transformation, we identified
1 Uniform Recall Procedure for Therapeutic Goods, Australian Government, the need to implement scanning of products on receipt,
Department of Health and Ageing, Therapeutic Goods, © Commonwealth of
Australia 2004.
put-away, picking and packing.
CH2 worked with those suppliers already using GS1 Bar Cottman was a business with 50,000 line items, very limited
Codes to ensure these were entered in our database and eMessaging capability, no scanning and no use of the GS1
then began their scanning based on these products. For System. This had to be merged with CH2’s 32,000 line items.
those products without bar codes, CH2 applied internal
identifiers and bar codes at carton level so we could track As a result of the work CH2 had already done to implement
products and their location in our warehouses. Applying GS1 Bar Codes and eMessaging with suppliers, we
these internal labels has been clearly recognised as a non- found that we were in a strong position to merge the
value adding process, and elimination of this process by two businesses using the scanning processes we had
provision of supplier GS1 Bar Codes, has been identified as a implemented in our existing warehouses.
key focus moving forward.
In what amounts to proof that using proprietary item
Of the CH2 suppliers, approximately 240 are now providing identification does not cross-translate within the industry,
GS1 GTINs and appropriate bar codes, however it is CH2 were only able to match 3.12% of items between the
recognised that there is much more work to be done to two businesses using their vendor part number. This was a
engage the remainder of the 900 suppliers. To address this, startling revelation and is a strong reason for the industry to
CH2 is partnering with GS1 and commencing a supplier get on board to use GTINs for item identification. The advent
engagement and education program. of the National Product Catalogue meant that there was
now another valuable data source that was useful for the
The ultimate goal is to have products carrying bar codes, as data matching exercise.
the business benefit is clear. With the bar code scanning proc-
esses in place CH2 warehouse pickers are now picking and CH2’s purpose-built warehouse in South Australia was the
packing up to 400 lines a day, a very significant productivity company’s first site for physically merging the inventory of
improvement compared to the pre-scanning days. the two businesses. As a result of this merge, 500 pallets
were moved in a day and put into bar coded locations. The
Organisational Consolidation merger was completed in 1.5 days and scan packing was
In early 2008 CH2 acquired the Cottman Australia business, then enabled in the warehouse. The Western Australian
extending their supply offering to other trading partners. operations were merged next and by using scanners to
Customer focus
Turning to the customer side of our business, CH2 has
initiated a multi-streamed eMessaging protocol using both
GS1 XML and GS1 EANCOM.
CH2 is confident that improved data interchange and
The first stream entails establishing eMessaging with public collaboration between wholesalers and manufacturers and
and private hospitals. This involves a business-to-business based on the GS1 standards will reduce stock holding across
(B2B) model with hospital pharmacy customers, using the the entire supply chain and ultimately lead to improved
GS1 System based on EANCOM messaging standards for pur- patient safety.
chase orders, purchase order response and despatch advice.
The backbone of this system is accurate and reliable product
The second stream relates to CH2’s proprietary online data and CH2 is working to implement the National Product
ordering system - Simple Order System (SOS). This system is Catalogue, the Australian Healthcare data synchronisation
used by the majority of customers not using EANCOM. CH2 solution hosted on GS1net, both as a recipient of supplier
is moving SOS to the GS1 standards and we have recently data and a source of data to their customers.
added a GTIN search capability.
CH2 understands the value of quality data and is committed
Already, Melbourne’s The Alfred Hospital Pharmacy, a to implementing the GS1 System through our business
400-bed, acute tertiary referral hospital renowned for its and with our partners. The use of the GS1 standards for
specialist services, uses the SOS ordering system with eMessaging, GTINs, GLNs and SSCCs are paramount to our
products identified by GTINs. industry moving forward. We believe the uplift in quality
systems will lead to improved patient safety.
Looking forward
CH2 will continue to drive the implementation of GS1 This is a very long journey for the Australian healthcare sec-
eMessaging with suppliers and encourage them to apply tor and we are just at the beginning. As a middle player we
GS1 Bar Codes to all levels of packaging as well as SSCCs to see suppliers taking steps to implement the GS1 System and
logistic units. Our vision includes being able to receive batch now hospitals are making demands on us for a system that
and expiry date information in electronic messages and to will give them better inventory management and traceabil-
have that information physically bar coded on the products. ity. This work requires patience, persistence and passion.
Author
Ged Halstead is the Chief Information Officer for CH2. He has in which Ged has implemented financial, distribution and
over 20 years experience implementing ERP systems for a broad warehouse systems are petro-chemical, print media, grocery
range of industries in Australia and the United States. Ged has wholesale and frozen foods.
spent 12 years in the IT consulting space, principally engaged Ged is actively involved in the Healthcare standards
as a project manager and practice leader. He has 10 years in the community, notably as the current Chair of the GS1Healthcare
healthcare industry delivering solutions for global leading brands User Group Australasia, on the leadership team for the Monash
in both medical devices companies here and abroad, and to Medical Project, a member of the GS1Net advisory group, as well
medical services companies and pharmaceutical manufacturers as participating on advisory groups for a number of eCommerce
in Melbourne, Sydney and Auckland. Other industry sectors exchanges.
Abstract
Introduction can be traced from the point of return to the unit through
In France, as in other countries around the world, UDI of to their distribution to clinical services. The individual steps
surgical instruments is not yet regulated1. However, several of the process are presented in the figure 1 and for each of
French hospitals are undertaking their own UDI projects. these steps, the agents must identify themselves.
Consequently, if the instruments in the box changed, that laser DataMatrix 2D keydot DataMatrix 2D
barcodes barcodes
change was not traceable. The decision was therefore
taken to trace the individual instruments in addition to the
surgical boxes. RFID tags and DataMatrix 2D barcodes are the two carriers
that can be used in the operating theatre and sterilization
Several important points were considered before the units. RFID tags on instruments could help avoid them being
project: left inside the patient2-3. This system could also assist in the
1. What level of traceability do we want? exchange of data between hospitals and to confirm the
2. What kind of carrier will we use? contents of surgical boxes.
3. Which instruments will we identify?
4. What kind of code will we put on each carrier? DataMatrix 2D barcodes are represented in 2 dimensions
(2D). They can be applied to instruments directly with a label
What level of traceability do we want? or marking by micropercussion or laser.
In France, instruments are dedicated to a box. When an
agent is assembling a box, the t-doc software displays its For this project we chose the most pragmatic system of
composition on a computer screen and the agent scans identifying the surgical instruments with a DataMatrix 2D
the instruments and must only include the associated barcodes. 3 major reasons lead to this choice:
instruments into the box. 1. the ease of laser marking existing or branded new
instruments; Indeed, 500 instruments were industrially
This concept is very simple; it is easy to assemble surgical marked per week.
boxes and to identify the previous procedure/patient where 2. the cost of this kind of marking. In fact, a single laser
the box was used. But there is little difference between this mark costs between 2 and 3 Euros, whilst an RFID tag
level of traceability and the traceability of a box. costs approximately 7 Euros4.
3. the existence of software that enables this kind of
In the Robert Ballanger hospital instruments are dedicated traceability.
to a box, but it is possible to put the instrument in another
box. But, as the level of identification is at the individual For clinical services instruments, cost effective keydots were
instrument level, traceability can be done on the box, for chosen.
each instrument or for each box that included a particular
instrument.
References
1. Medical devices and AIDC, UDI, traceability, efficiencies, global standards: Fact, future or fantasy? Eucomed, Medtech Forum, Bruxelles, 2008.
2. RFID tags help alert surgeons to problems. Healthcare Benchmarks Qual Improv 2006; 13: 118-20.
3. Rogers A, Jones E, Oleynikov D. Radio frequency identification (RFID) applied to surgical sponges. Surg Endosc 2007; 21:1235-7.
4. Landanger B. Snitem Info 2008; 175: 5.
Authors
Georges Nicolaos is Head of the Sterilisation Unit of the Frédérique Frémont is Organisation Engineer at C.H.I Robert
Robert Ballanger Hospital. Georges is also Vice-Chairman of the Ballanger. Prior to joining Robert Ballanger Hospital, Frédérique
committee for the prevention of the nosocomial infections and worked for more than 10 years in healthcare consulting as Senior
member of the Committee for the Protection of Person in the Manager in Ernst & Young Healthcare and as Project Director at
biomedical research. L.F.B. (plasma-derived medicinal products and “biotech” products).
Frédérique is a member of Cologh (Hospital group member of the
French Logistic Association) and GS1 Healthcare France.
Abstract
Healthcare and information An example from the English NHS illustrates this point well.
Healthcare is an information intensive environment and the Figure 1 provides an extract from the NHS Purchasing and
availability of quality information is essential for the delivery Supply’s Agency’s pharmacy database which collates details
of safe and effective healthcare services. Decisions based of orders placed by NHS Trusts. The database contains 130
on poor quality information provide ineffective healthcare different descriptions, 30 of which are shown in figure 1, of
services which adversely affect the outcome of treatment a single product, Bleomycin 15,000 unit powder solution for
for patients and provide the NHS with a significant and injection vials.
avoidable cost.
The lack of a common commercial and procurement data
The healthcare service in the UK is provided by a large standards in the NHS means that the analysis of expenditure
number of organisations involving the private sector, the and demand requirements across organisations is very costly
NHS and an increasing use of the retail sector. An equally in terms of time and resources. Without standards to accurately
large number of suppliers of goods and services supply into identify products and suppliers the accuracy can never be
this network of healthcare providers. Purchasing and supply certain and visibility across the NHS is limited.
is essentially about relationships between organisations and
processes; more effective processes and better relationships Effective information is the key foundation to an effective
provide a higher quality supply chain. supply chain and effective healthcare.
To achieve stronger and effective processes and Processes and data standards
relationships, within and between organisations access to The implementation of common data standards across the
high quality information is required. To enable the effective procurement and commercial systems by NHS organisations
delivery of high quality information organisations on the and its suppliers also enables information to be easily trans-
buy and supply sides of the healthcare network must be ferred between systems. This enables interoperability between
able to share data and order to achieve this common data systems, allowing automation which reduces the resources re-
standards are required. quired, removes errors, increases compliance and reduces risk.
Current NHS position Beyond the business benefits the implementation of common
The NHS has adopted a fragmented approach to the procurement data standards enables traceability and this
management of procurement and commercial information directly contributes to improvements in patient safety. This
and systems and consequently the lack of common data was demonstrated in Coding for Success – simple technology
standards has created many data silos. Data is available in very for safer patient care, a Department of Health policy document
large volumes however quality information is in short supply. published in February 2007.
Figure 1
Procurement eEnablement technologies of this activity; the text inside the arrows describes the
Procurement eEnablement is the application of information processes undertaken and the text outside the arrows
and communication technologies to the commercial and describes the eEnablement technologies.
procurement functions. Figure 2 provides an overview
Figure 2
Sourcing Purchase
to pay
Process steps
eEnablement technologies
Procurement eEnablement technologies are important The outputs of the programme are delivered through a
to the NHS as to be effective they demand common data range of projects which have two levels of delivery:
standards across the NHS organisations and their suppliers. • Level 1 projects establish common data and business
Implemented procurement eEnablement technologies message standards for commercial and procurement
provide the NHS with an important opportunity to systems; provide a library of knowledge and guidance in
significantly enhance its capability to manage procurement conjunction with a range of tools for the NHS to improve
information, improve its commercial and procurement awareness and understanding.
processes and remove waste and duplication. • Level 2 projects drive the delivery of procurement
eEnablement capability into the NHS by directly
Procurement eEnablement and the NHS providing resources to work directly with NHS
Though the NHS has been using procurement eEnablement organisations, suppliers and technology providers to
technologies since the early 1990’s the approach to achieve the following:
the implementation of these has been fragmented. – The capability for all procurement eEnablement
Consequently the NHS has a wide range of standards in use systems in the NHS market to support NHS standards
and therefore limited interoperability between systems and and interoperability requirements.
little visibility of its expenditure across the network. The NHS – The capability within NHS organisations to make
has also failed to exploit sensible once-only opportunities appropriate use of procurement eEnablement
that procurement eEnablement technologies offer; such as technologies.
the management of product data for electronic catalogues – The capability within the NHS to co-ordinate
and pre-qualification. investment in procurement eEnablement
technologies.
NHS Procurement eEnablement – A transfer of skills and knowledge into NHS
Programme organisations to establish a mature understanding of
The NHS procurement eEnablement Programme (NPEP) is procurement eEnablement by NHS organisations.
about providing the NHS with the capability to effectively – To implement a once-only approach to the provision
use procurement eEnablement technologies and achieve of product and pre-qualification data.
the significant benefits that are available. The programme
implements the strategy Procurement eEnablement in the The NPEP projects were developed in consultation with a
NHS, June 2007. range of stakeholders from NHS organisations, suppliers
of goods and services and technology providers. The
At the core of the programme is the implementation of NHS Procurement eEnablement Programme is focused
common data standards for procurement and commercial on delivering pragmatic steps that put into place the key
processes. enablers required for the effective implementation of
procurement eEnablement technologies in the NHS and
The programme has four key outputs, described in Figure 3. drive forward the adoption of these technologies.
To provide a clear direction for the NHS, its suppliers and technology providers on the requirements
Direction for NHS procurement eEnablement. Through the provision of a strategy and then a model that
describes the capability requirements.
To put into place a strong awareness and understanding in the NHS of the benefits available from
Awareness and
procurement eEnablement, the current position of the NHS and the actions that are required to
Understanding
enable the significant benefits.
To establish NHS data and business message standards and requirements for interoperability between
NHS Standards
procurement eEnablement systems and provide guidance.
To significantly improve the capability of the NHS to effectively implement and utilise procurement
NHS Capability
eEnablement technologies.
The level 1 projects are funded by the NHS Purchasing and Classification
Supply Agency and work on these commenced in mid The NHS standard for classification is NHS-
2008/09.The level 2 projects will be run over a three year eClass. This classification system is owned
period and require significant additional funding for which by the NHS and is mapped to several other
a business case has been presented to the Department of classification systems to ensure that NHS-
Health (October 2008). eClass can provide an effective analysis of
expenditure.
NHS Procurement data standards
The key building blocks of common data standards for NHS NHS Procurement eEnablement
commercial and procurement processes are coding systems Delivery Group
that enable the unique identification of suppliers and The NHS Procurement eEnablement Programme is owned
products and a classification system to enable the analysis of by the NHS Procurement eEnablement Delivery Group
expenditure. The NHS standards are: (NPEDG), the NHS stakeholder group for procurement
eEnablement, which was formed in late 2006. Membership
Supplier codes of NPEDG is drawn from organisations across the NHS and
Duns numbers from Dunn & Bradstreet are includes representatives from the home countries. The
the NHS standards for supplier codes. Duns current Chair of the group is Chris Slater, Head of Supplies
numbers are available free of charge for all from Leeds Teaching Hospitals NHS Trust.
legal entities. The NPEP programme has
provided a web portal to enable suppliers In June 2007 NPEDG published a strategy for procurement
and the NHS to identify Duns numbers. eEnablement in the NHS within ministerial sponsorship
and the NHS Procurement eEnablement Programme
Product and location codes implements this.
GS1 GTINs (Global Trade Item Numbers) are
the NHS standard for products and GLNs for For further information visit www.pasa.nhs.uk or contact
the identification of locations. [email protected].
ReferenceS
• Coding for Success – simple technology for safer patient care, Department of Health, February 2007
• Procurement eEnablement in the NHS, NHS Purchasing and Supply Agency, June 2007
Author
Rachel Hodson-Gibbons is a purchasing and supply Manager for medical equipment and working with the
professional and currently holds the post of Head of development of Collaborative Procurement Hubs for the NHS
eProcurement for the NHS Purchasing and Supply Agency Purchasing and Supply Agency.
in which she is leading the NHS Procurement eEnablement Rachel is a member of the Chartered Institute of Purchasing and
Program. Rachel's most recent posts have been Category Supply and holds an MSC in Procurement.
Abstract
The Leeds Teaching Hospitals NHS Trust’s demand management project has
produced significant efficiency savings in the orthopaedics supply chain. The
project highlighted the need for global synchronisation of product codes for
Article by Graham Medwell
automatic identification and data capture, including RFID within healthcare.
Background they are used, to ensure that the true cost of that procedure
Leeds Teaching Hospitals NHS Trust started to roll out is recorded accurately. In orthopaedics there is an additional
materials management in 1999 and now has over 270 requirement to record any implanted products and update
materially-managed stocking points. It has derived the National Joint Registry (NJR) for track-and-trace.
significant benefits from controlling stock levels in major
areas like Cardiology, where stock usage is updated live on The vision at Leeds is that the patient administration system
the system through barcode scanning at the point of use. and the stock systems are integrated to update stock
records and patient data automatically in order to improve
The Chapel Allerton Orthopaedic Centre (CHOC) was an accuracy and provide live data to suppliers and the trust
area identified in 2006 as a priority for increased stock budget holders. The data recorded would be invaluable in
management and as a stand-alone service for elective supporting activity-based costing.
surgery (orthopaedic trauma carried out at the Leeds
General Infirmary) which had a problem with high Data flows – the challenge
stock levels and system integrity problems arising from Within healthcare, unlike other sectors, there is a lack of
consignment stock and vendor-managed inventory. The consistency in the identification of product within the
system became known as “CHOC Stock“ and is now linked supply chain. It is for this reason that Leeds Teaching
to the main patient systems enabling product costing and Hospitals has been a major supporter of the DH in the
track and trace of product. implementation of GS1 standards. From our experience
in linking manufacturers’ bar codes to product within
The wider healthcare vision cardiology and radiology, we understood the scope of the
Patient safety was at the forefront of the DH paper ‘Coding problem in mapping thousands of codes within our systems.
for Success’ which featured ‘islands of application within the The suppliers of the products had no means of providing
NHS’ of Automatic Identification and Data Capture including the data, so we were left with the following alternatives:
the bar coding system implemented in the Leeds Teaching • Map the codes ourselves
Hospitals’ Catheter Labs. The report highlighted that around • Use our own bar codes
10% of NHS inpatient episodes result in errors of some kind
– of which 50% are preventable. Of 8 million admissions We decided to map the codes ourselves, but work with
each year, about 850,000 result in patient safety incidents the suppliers through GHX, the healthcare e-commerce
that cost the NHS £2billion in extra hospital days. exchange provider, to enrich the data used throughout the
supply chain. In September last year GHX announced that it
With the advent of payment by results, it is important that was to become a GDSN-certified data pool to accelerate use
consumables are recorded by each procedure for which of GS1 standards in healthcare.
from the contracts was then enriched (classified, coded and actually used, the information on costs by procedure and
priced) and fed from the GHX Nexus catalogue system to implant data for the National Joint Registry can be recorded
the inventory system. in real time.
Note
PowerGate Locally known as CHOCSTOCK – is the stock
Output from PAS to CIS and PowerGate
control and forecasting system
Knife-to-skin time
CIS Clinical Information system
Closure time
PAS Patient Administration System (isoft Galaxy)
Out-of-department time
Author
Graham Medwell is the Business manager for the Leeds as working on health event linkage for the local health authority.
Teaching Hospitals NHS Trust, with sixteen years experience in He is a member of the GS1 UK HUG and the NHS National
developing purchasing systems within the public sector as well e-Enablement Programme.
Abstract
Figure 1
for applying AIDC technologies; data capture can provide
information as follows: Data
• When the surgery started and ended Matrix
• When and by whom instruments were retrieved and
washed
• Which instruments are in each container
• How often instruments are being used
• When and which instruments have been repaired
• When, how and by whom the container were set,
sterilized and stored
• Which patient the instruments were used upon (AIDS,
Creutzfeldt-Jakob disease, etc)
UDI for Metal
instruments
Not only simplification of the task but also recording of event
history will become possible with using barcodes and RFID. Scanner
Introducing Unique Device Direct part marking to each instrument was carried out on
Identification and Traceability its flat mirror–like surface by laser printing in cooperation
As a unique device identification (UDI) for metal instruments with Mizuho Ika Kogyo Co. Ltd. Durability of barcode
we have employed DataMatrix, two-dimensional bar code, printing to rust and friction had already been proven
3~5mm square in size, according to the guideline of JAMEI through five-year tests. Reversed reading was chosen for
(Japan Association of Medical Equipment Industries). increased legibility of barcodes.
EV EV
Assortment
Washing Washer disinfector RFID reader
for sterilization
Decontamination Assembly
EOG sterilization
Instruments are grouped together into a set by surgical • Two at the exit of high pressure steam sterilizer
procedure and housed in a container. For identifying the
container an RFID tag was applied to it.
RFID tag
Multiple containers are put into the sterilizer with the
tagged face directed left. When sterilisation is completed
and the containers are pulled out from the opposite
side, tags are simultaneously recognised by the antenna
at the exit. Data relating to sterilisation are recorded,
namely which sterilizer was used, when sterilisation
started and ended, completeness of process, name of
RFID antenna the set and method of sterilisation.
• One at the exit of the SSU
Finally containers are sent to the OR via EV for storage.
After here, used instruments proceed along the arrows The RFID antenna set here collects date of supply and
shown in figure 2. name of the set.
Reference
MIZUHO IKAKOGYO CO., LTD, 30-13, Hongo 3-Chome, Bunkyo-Ku, Tokyo, 113-0033, JAPAN, http://www.mizuho.co.jp
Author
Dr. Chikayuki Ochiai, M.D., D.M.Sc is the Chief Executive of neurosurgery in Dokkyo University School of Medicine, as head
Kanto Medical Center NTT, Tokyo. After graduating from the of neurosurgery in JR Tokyo General Hospital, and as head of
University of Tokyo, Faculty of Medicine in 1971 he majored in Neurosurgery in Kanto Teishin Hospital (present Kanto Medical
neurosurgery. Before being promoted to his current position in Center NTT EC). He experienced more than two thousand
2002, he held various posts including a professor of neurosurgery surgical cases in his career as a neurological surgeon.
in the University of Tokyo Hospital, as assistant professor of
BPOC/eMAR spotlight
on performance improvement
Abstract
In 2003, HCA started this initiative in their Richmond Market, HCA’s longstanding relationship with Medical Information
consisting of six acute care hospitals supporting 1620 operat- Technology, Inc. (MediTech), their hospital information
ing beds in Richmond, Virginia (USA). A major reason for system, made implementing their eMAR and BPOC system
implementing eMAR was to enable the healthcare provider extremely easy. The system integration allowed nursing and
to administer medications with confirmation of the Five pharmacy to communicate in real time and improve patient
Rights of medication administration: right patient, right dose, safety. The systems also provided data and information that
right route, right time, and right medication. Secondarily, the was never captured before, including medication errors.
Figure 3
Competency/not trained
ACK incorrect/omitted
Illegible handwriting
Duties not performed
Order interpretation
EvCode
Order entry error
Order execution
Order missed
Inattention
Other
Improper dose 185 115 47 15 19 21 20 17 18 19 17 17 16 18 14 9 8 8 10
specific causes assigned to each general cause. Once the list reporting and categorizing medication errors. This team
was finalized, staff education was done to ensure the coded also provided leadership for medication error reduction
of errors was consistent in each facility. A recommended and process change, monitor data integrity, interpret data
team of pharmacy, nursing, risk and quality professionals with trending analysis, and identify systems breakdown. This
within each facility was charged with reviewing each error group focused on performance improvement activities that
and applying the correct error cause codes. This process was could be implemented in our hospitals to prevent future
done weekly in many of our facilities to ensure medication medication errors.
events were analyzed in a timely manor.
Post eMAR Implementation: Performance
Error tracking based on specific cause codes was provided Improvement Activities
to each facility on a monthly basis while trends throughout By analyzing our medication event data and through direct
the health system were reviewed and performance observation of the medication administration process we
improvement processes were implemented. By using this have identified several key areas for performance improve-
taxonomy medication errors can be tracked and trended ment: only medications with viable barcodes reach the
within each institution and provide a system-wide approach patient, all medication should be scanned before administra-
to establishing safe medication practices in all facilities. For tion, and scanning all pills required for a complete dose.
example in Figure 3, we found the most common cause or a
patient to receive the wrong dose of medication (improper It was imperative as part of the pharmacy process to ensure
dose, wrong form, or wrong strength / concentration) was each unit-dose or unit-of-use medication reach the patient
due to pharmacist order entry errors. But we also found with a viable bar-code. During the drug procurement
mathematical calculations, physician prescribing and process, our pharmacies tried to source only bar-coded
communications also contributed to these types of errors. medications. This strategy was supported by our contracting
department in selecting pharmaceutical manufactures
At a corporate level, a small team of pharmacy, quality that bar-coded their products. Our purchasing process
and nursing professionals then developed training tools required the scanning every medication received in our
and system changes to assist individuals at each facility on pharmacies. For those medications without bar-codes or
those medications where the bar-codes would not scan, package was scanned twice to complete the administration
pharmacy would quarantine those products until a bar-code of this order. In both of these cases where only part of the
could be applied. dose was scanned, patient safety checks are bypassed.
During direct observation many medications were either These and other “short-cuts” or “work-a-rounds” start with the
not scanned or scanned after the medication administration pharmacy ensuring proper, viable bar-codes. This important
process. Several factors contributed to these work-a- rounds, quality assurance process begins in the pharmacy and must
but on of the most common reasons given by nursing staff be done for every medication procured and ultimately
was the reliability of the medication bar-codes. If an individual dispensed for patient administration.
medication package failed to scan correctly, the nurse was
required to wait for the pharmacy to resolve the issue or Conclusion
replace the package. We found some nurses would save an In conclusion BPOC is one of the most important
empty package they knew would scan as a back-up and technologies we can use in our hospitals to improve patient
therefore not having to wait for pharmacy to resolve the error. safety. Bar-code technology is used in virtually every industry
and for multiple applications. Health-care must implement
Many of our medications require multiple tablets to equal the and maximize the patient safety benefits from BPOC.
prescribed dosage. For example, an order for acetaminophen
650mg required two 325mg tablets. We experienced
incidents where only one table was scanned or the same
Author
Noel Hodges is a licensed pharmacist in the Commonwealth provides continuous monitoring of bedside scanning
of Virginia. As the Director of Pharmacy Services for HCA compliance and patient safety. He was also responsible for
Central Atlantic Supply Chain, he is responsible for facility developing a centralized bar-code packing operation for
supply chain pharmacy operations and to identify and his health-system. He has authored multiple articles and
execute continuous improvement opportunities. Hodges presented posters at American Society of Health-System
completed his pharmacy degree at Purdue University and Pharmacists meetings and The National Patient Safety
his Master of Business Administration from Strayer University. Foundation on the topic of eMAR and BPOC. He has spoken
Hodges led the pharmacy implementation of Electronic locally, nationally and inter-nationally on bed-side scanning
Medication Administration Records (eMAR) and Bed-side system, drug packaging, and BPOC.
Point of Care (BPOC) for the HCA Richmond Division, and
Abstract
The premise of the GS1 System is that by introducing or created using the GS1 company prefix of the issuing
standards to key aspects of supply chain identification and GS1 member company, to identify physical, functional and
communication, organisations can more easily implement legal entities during electronic messaging exchanges. GS1
best-practice processes because all trading partners will identifiers provide trading partners with an accurate and
understand the standards used and not request proprietary abbreviated means of referencing entities, trade items, and
solutions. Everyone speaks the same language when logistics units in their databases.
standards are used. This project used GS1 Standards for
identification, electronic messaging, bar coding and data GS1 EANCOM provides a standardised and predictable
synchronisation. structure for electronic business messages, enabling
business partners to communicate business data rapidly,
The GS1 System identifies trade items using Global Trade efficiently and accurately, irrespective of their internal
Item Numbers (GTINs). These are internationally unique, hardware or software. As a subset of the UN/EDIFACT
non-significant numbers assigned by GS1 members (who standard (United Nations Electronic Data Interchange for
are product brand owners) using their GS1 company prefix. Administration, Commerce and Transport), GS1 EANCOM
Each different variant of an item and packaging level is provides for the collection of the message elements
identified by a different GTIN. needed by business applications and required by the syntax
(mandatory elements). GS1 EANCOM also incorporates the
Logistics units are identified using Serial Shipping Container GS1 standards for the identification of trade items, logistics
Codes (SSCCs). These globally unique identifiers are issued units and trading partners which allows for the integration of
by the creator of the logistics unit, using their GS1 company the physical flow of goods with related information sent by
prefix. Global Location Numbers (GLNs) are issued by GS1 electronic means.
AuthorS
Nigel Allsop is Manager, Strategic Procurement, Health Service Institute of Australia and in 2008 the Customer Support
Purchasing Victoria. Nigel brings over 17 years experience to HPV team won the Baxter Global Supply Chain Award. Anthony is
covering such diverse areas as supplier management, strategic a licensed customs broker and holds a number of business
procurement, inventory management, E-procurement and qualifications.
process improvement across commodities and services. Nigel has Ian Larmour has been a Director of Pharmacy, at a number of
achieved qualifications in Masters of Business, Bachelor of Arts major hospitals, since 1981. Currently he holds the position of
with Honors in Business Studies, after successfully completing a Director of Pharmacy for the Southern Health group of hospitals
trade apprenticeship as an Electrician. in Melbourne. Ian is a member of the Melbourne Teaching
Ged Halstead is the Chief Information Officer for CH2. Hospital Drug Usage Group (now called Victorian Therapeutic
See page 18. Advisory Group) and was Chairman from 1993 until 1995. Since
Anthony Keyes is Customer Support Manager, Australia and 2000, Ian has been a member of the Victorian Ministry of Health
New Zealand, Baxter Healthcare. Anthony has over 30 years Poisons Advisory Committee. Over the years Ian has been
experience in the healthcare industry. Anthony started with involved in a variety of other organisations in a diverse range of
Baxter in 1978 and has been managing Baxter’s national roles and has published many articles on a wide range of topics,
Customer Service and Homecare divisions in Australia since 2004 most notably a prospective study of Hospital Admissions due to
and New Zealand since 2006. Anthony was awarded the 2006 Drug Reactions (AJHP, 1991, 21, 90-95).
National Customer Service Manager of the Year by the Customer
Abstract
The role of the federal narcotic control office consists Refdata has contracted with e-mediat Ltd for the operative
(among else) in collecting the declarations and providing activities, consisting in maintaining and developing the
appropriate information to the local authorities so that they reference databases with GS1 identification keys for the
can proceed in on-site controls where and when necessary. Swiss market.
The power of the narcotic control system is to deliver within
30 days a country-wide picture of all transactions involving Project participants
narcotics for medical use, and therefore concentrate Lead of the pilot is delegated by Refdata to a
on observations revealing peaks and other suspicious pluridisciplinary team grouping representatives of
movements. wholesale, manufacturers, pharmacists and GS1 Switzerland.
E-mediat, a service provider which is managing databases
By disposing of that IT infrastructure (which can be accessed for the healthcare market in Switzerland, has been
through the web: http://www.abeko.swissmedic.ch/) and designated to manage the project and develop the
by building on GS1 identification keys used for several necessary IT infrastructure. Pilot participants were invited to
other purposes on the marketplace, narcotic control monitor the project from its conception to its delivery in a
is managed in the most cost-efficient possible way, by few joint meetings.
providing accuracy and full coverage to the federal and local
authorities. It is further estimated that the user community Technical concept
saves considerable workforces because of the integrated By tracking and tracing individual drug packs, the project
processes with non-specific identification keys. corresponds to the US-Pedigree model; full traceability is
provided by documenting each “event” during the journey
Refdata foundation of each pack, from the manufacturer’s premises (or its
Refdata foundation (www.refdata.ch) has been launched representative), to the dispensing to the patient.
in 2001 to group efforts and to maintain directions
taken by a previous organisation. Its objective consists in The project was planned for a limited time frame: 3
securing identification of pharmaceuticals and healthcare months. As a consequence it was not foreseen that each
providers across the country, with GS1 keys. Nearly all project participant integrates the new processes into its
the Swiss healthcare industry is represented in Refdata’s operational IT environment; a separate “in vitro” framework
board: Associations of Pharmaceutical, Medical Devices has been developed by e-mediat Ltd, which allowed some
manufacturers and wholesalers; for the care givers, the simplifications (i.e. only one “event” database; central serial
associations of medical doctors, pharmacists, droguists number allocation).
and hospitals; for the insurance side, the association of
illness insurers and the pool of federal insurances (accident, The set of operations was therefore built on a web-
disability, etc.). Swissmedic and the Federal Office for Public application with a safe level of protection and access. Each
Health participate as observers. project participant accessed the web-application with its
own data and had visibility to the previous and the next step
in the supply chain. Only Swissmedic benefit of full overview The pilot was limited to 3 months: compliance in
through the supply chain, so that comparison with the usual maintaining separate, additional processes on a relatively
monitoring system became possible. large scale was a challenge; it was not necessary for the
pilot to request longer efforts from the participants.
At the end of the project, participants are informed about 38,825 retail packs have been serialised and traced in
aggregated data, whilst Swissmedic receives all details to 7,221 events. Because the small number of participating
assess the results towards the usual monitoring system. pharmacies, only 281 retail packs made their journey
within project participants. Manufacturer (pre-wholesalers)
Project participants delivered 23,504 retail packs to project participants, mostly
and selected project products wholesalers. Cross checks made by Swissmedic on about
Four Pharma Manufacturer (Janssen-Cilag, Mundipharma, 3,000 data sets, based on the narcotic control processes in
Novartis Pharma [pre-wholesaler: Voigt], Pfizer [pre- place, and demonstrated consistency of the collected data
wholesaler: Alloga]) joined the pilot by selecting one pack within Smartlog. The reduced number of discrepancies
size of one of their controlled products. All the wholesalers (~1%) concerned recipient identification in
participated with a small number of retail pharmacies.
The project did not address hospitals: the supply chain Smartlog’s records and was due to the non-integration of
to hospitals in Switzerland is very simple because they the processes and to human errors in selecting the recipient
are usually supplied directly from manufacturers or their of a delivery.
representatives.
Project outcome
Participant feed-back has been very positive in general.
Without surprise, wholesalers declared that optical marking
is not appropriate to track and trace at the speed they have
to work in preparing deliveries. Retail pharmacies expressed
their interest in disposing of a better instrument for their
stock management, including the management of recalls.
SGTIN
event
GLN
GLN Prescribing MD
Patient (anonym)
Conclusions and vision For GS1 Switzerland’s user community, Smartlog helped
From a series of articles in the specialised press across understand the need to develop good practices in the
the country to the adoption of the final reports, through delivery processes, especially between suppliers and
the running of the pilot, numerous actors in the Swiss hospitals. A working group has been set up immediately
healthcare have developed a better understanding of after Smartlog to address this subject.
the benefits of an extensive use of GS1 standards for their
daily operations. The reports, which are publicly available We expect the federal authorities to dispose of a good
(www.gs1health.net/smartlog), list statements and lessons information base in the case of any sudden incident
which help stakeholders in preparing future activities. This involving the trade of counterfeited drugs, through the
includes hospitals, even if these were not part of the pilot (in usual supply chain.
Switzerland hospitals are currently mainly supplied by the
manufacturers or their local representative; the supply chain
is therefore the most direct possible and excludes practically
any counterfeiter to supply its pharmaceuticals to hospitals).
Authors
Laurent Médioni is currently canton’s pharmacist in Fribourg. He Christian Hay works currently for GS1 Switzerland and
was previously head of the Swiss narcotic control office and led GS1 Global Office. Educated as a lawyer, he worked for the
the reengineering of narcotic control in the early 1990. He started pharmaceutical branch since mid of 1980s in various positions.
his career as a hospital pharmacist in a regional hospital before He was involved since the early stages in GS1 standard
joining his first position as canton’s pharmacist in Neuchâtel. deployment in the Swiss healthcare.
Beside narcotic control, canton’s pharmacists are in charge of
surveying retail and hospital pharmacies and to maintain plans
for public health, as in the case of pandemics.
Abstract
The New Direction between the two boards. The pharmacy board is also
All of the necessary building blocks are in place to create the supported by a Pharmacy Standards Work Group.
groundwork for future success. Already, we are beginning to
see the results of these efforts, including: The proper structure for future success is now in place.
CareNET brings the membership of devoted providers,
• The former CareNET Board of Directors (10 hospitals, 10 suppliers, GPOs and service providers to the table.
suppliers) remains in place as the CareNET Healthcare GS1 Canada brings an association with many years of
Sector Board in GS1 Canada, with the mandate to set the experience in e-commerce and supply chain standards.
future direction for healthcare in Canada More importantly, the onerous demands on volunteers to
continue the momentum will be supplemented with the
• A majority of board members have also agreed to partici- experience of GS1 Canada staff.
pate on a newly-formed CareNET Healthcare Standards
Council to approve the future direction for healthcare What Are We Trying to Achieve?
standards development and implementation timelines Our ultimate goal is to achieve a standardized, efficient
healthcare supply chain. This very simplistic statement,
• A Healthcare Technical Standards Working Group although it defines the objective, requires a great deal of
has been formed to create the standards for future advance planning and work.
e-commerce in healthcare. This group of more than 30
individuals from across Canada, comprised of hospitals, Clearly, the initial benefits are obvious. By implementing
suppliers, distributors, GPOs, network gateways (Value- a standards-based supply chain, using technologies that
Added Networks) and service providers, will prepare the are designed with a global perspective, reduced costs will
recommendations for future standards and forward them accrue to both the provider and supplier community. This
to the CareNET Healthcare Standards Council for approval. cost effectiveness will enable additional funding to be
directed to patient care.
The GS1 Canada Healthcare Pharmacy Sector Board will
have a representative on the CareNET Healthcare Sector Moreover, using global standards – such as Global Trade
Board, and vice versa, to ensure the transfer of knowledge Item Numbers (GTINs) and Global Location Numbers
500
450
400
350
300
250
200
150
100
50
0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
(GLNs) for product and location identification, respectively To properly develop the systems of the future, Canadian
– throughout the supply chain will enable track and trace healthcare must define the basic requirements for the
systems and automated product recall systems. Industry- exchange of electronic business documents. These basic
adopted attributes and the exchange of clean data between requirements will include global data requirements such
trading partners will ultimately become entrenched in as GTINs and GLNs to facilitate the tracking of products
healthcare systems and drive efficiencies. throughout the supply chain. Just as the retail and grocery
sectors have successfully demonstrated for many years,
The final achievement will be enhanced patient safety. Future guidelines for basic bar coding of all medical products
systems will track a product throughout the entire supply entering the healthcare supply chain will be implemented
chain, from point of manufacture to point of use at the and enforced. As Radio Frequency Identification (RFID)
patient’s bedside, ensuring that the right patient receives the becomes a widely used technology in healthcare, the
right dose of the right medication at the right time. standards will be implemented and available for all members.
Canada is not unique in moving forward with this plan for With all trading partners moving forward with a common
the future. This strategy is directly linked to the global GS1 set of global standards, products that arrive from within and
Healthcare initiative. Although we track the efforts of other outside Canada can move through the supply chain with
countries, we are confident that we shall soon have in place confidence, and can be tracked to determine both their
a sustainable model for others to follow. origin and their final destination.
Author
Herb Martin, in his role as the CareNET Manager, is responsible will identify projects that will support the adoption of a common
for the administrative tasks associated with the day-to-day system of global supply chain standards in healthcare institutions.
operations of CareNET. CareNET is Canada’s healthcare sector CareNET’s goal is to improve patient safety, cost efficiency and
strategy to standardize the healthcare supply chain. Through its staff productivity, and ultimately ensure Canada’s healthcare
amalgamation with GS1 Canada, CareNET represents over 450 trading partners are able to fully operate in an increasingly
Canadian healthcare providers and 95 leading suppliers. CareNET e-driven global supply chain (www.carenet.ca).
Abstract
Background On the other hand, the cost unit accounting data is supplied
The Herz-Zentrum in Bad Krozingen is a hospital specializing to the Institut für das Entgeltsystem im Krankenhaus (InEK)
in the treatment of cardiovascular diseases. It has GmbH for review, as required by law.
departments for cardiology, angiology and cardiovascular
surgery. The Herz-Zentrum has a total of 256 beds. Table 2: Sample data supplied to InEK GmbH (sample data)
Cost Cost
The project was initiated in response to the time-consuming Releasing In-hospital centre type Purchase
cost unit billing by Diagnosis-Related Groups (DRG IK location code group group price (€)
calculation): When the project started in 2006, some 65% of IK No Inventory No 7 1 1,456.53
patients, and the manual processes required much effort. IK No Inventory No 7 4a 29.07
IK No Inventory No 7 5 1,926.00
On the one hand, the hospital uses cost unit accounting as IK No Inventory No 7 6a 189.35
Table 1: Excerpt from cost unit accounting per DRG case (sample data)
Preparation for the Herz-Zentrum Bad Figure 1: GS1 master data in the hospital
Krozingen project
The project was approved by the hospital management in
February 2005 and has been in production since September
2007. The relatively long project duration was necessary so that
suppliers could have the opportunity to identify their products
with GS1 barcodes in accordance with the requirements.
Payment by InEK GmbH for hospital services is therefore also previous six to seven hours. The available data is reliable
incorporated in the overall analysis: and the hardware can be used flexibly for a wide range of
processes.
Table 6: Payment based on DRG calculation
Number of cases Total revenue p.a. The data scanned in by the functional departments is
p.a. (€2.03 per case) available to other departments for downstream process steps.
Before 0 €0.00 Transparency is increased since every area works with the
After 942 €1,912.26 same information. Additionally, it is now possible to simplify
Revenues €1,912.26 medical documentation, since the scanned product data,
including batch numbers, can be transferred into medical
An analysis of the documentation process as a whole gives documentation. This not only reduces the time spent on
the following result: entering data but also avoids potential sources of error that
can result from data that is classified or entered incorrectly.
Table 7: Time saved in the Herz-Zentrum Bad Krozingen
Process Time saved p.a. With the transparency that is created, products can also
Documentation in the functional departments 51:48:00 be traced within the organisation, since consumption and
Entry by the accounting department 29:45:00 movement of goods can be documented automatically. In
Controlling the allocation of materials 15:36:00 the event of recalls, the products in question can be located
Total 96:39:00 and returned quickly and systematically. Not only does the
use of automatic data entry systems make sense for products
where documentation is mandatory, but in the long term all
Greater transparency, safety and quality medical goods are likely to factor in such considerations for
In addition to the cost savings, there are also qualitative the sake of increased efficiency and patient safety.
benefits of scanner systems and uniform standards, such as
greater data transparency, safety and quality. In the hospital, the project encountered extremely positive
reactions, resulting in the gradual inclusion of other
Since the continuous entry of consumed material provides operational areas. With the support of management and staff
up-do-date figures of the articles in stock, the entire in the various departments, it will not be long before the
ordering process can be automated. When stock falls below hospital sees this project become part of daily practice.
a predefined amount, an order is automatically triggered.
This does away with stock planning, leading to yet another Since parallel processes lead to unnecessary expenditure of
enormous saving of time. If required, the purchasing time and the benefits speak for themselves, the hospital’s
department can also monitor stocks in real time. message to its suppliers is unmistakable: products need to
be identified with GS1 barcodes across all packaging sizes,
The Herz-Zentrum Bad Krozingen has established that enabling universal use from production to patient.
stocktaking takes only around 1.5 hours instead of the
Author
Holger Klein is Head of Inventory Management and Logistics at career at Herz-Zentrum Bad Krozingen within the procurement-
Herz-Zentrum Bad Krozingen in Germany, a health service centre and materials-management-department. Mr. Klein has extensive
specialised in cardiology, heart surgery, vascular surgery and experience within the healthcare sector and has been leading
angiology. Having finished his apprenticeship in international various standardisation projects. He was responsible for
business successfully, Mr. Klein studied business management optimising logistic processes in Bad Krozingen, including the roll-
at VWA (business college) in Freiburg. Afterwards he started his out of a scanner-based ERP system.
Abstract
Serving an area of 87,268 km2 and a resident population of over The inefficiencies resulting from a “multicentric” focus,
8 million inhabitants, the Andalusian Health Service provides which requires the provision of logistics resources in each
its primary and specialised health care via 1,491 primary care institution without taking into account the possibility of
centres, 29 hospitals and 8 blood transfusion centres. sharing organisational facilities or systems, and which is
the dominant model in public health systems and in some
It is equipped with 83,132 health care professionals (2007 private health networks, can and must come to an end
data) and a budget of 8,751,387,000 Euros (2008 data) for the by means of establishing integrated networks of logistics
purposes of providing these services. resources.
These figures give a clear idea of the magnitude of the At the beginning of this transformation process, the
challenge of equipping this organisation with a corporate Andalusian Health Service is setting as their strategic
logistics solution that meets the supply chain requirements objective the integration of the available logistics resources
of all its preventive care, medical assistance and health under a common operating model to enable their effective
promotion systems and services. and efficient coordination.
Transformation of purchasing Two central lines of analysis are distinguished under this
and logistics services approach: the first of these is to examine and assess the
The organisation of purchasing and logistics services has logistics resources available in the Andalusian Health
evolved significantly over the last decade. The “multicentric” Service. The second is to outline their integration strategy.
traceability, and the management of business messaging prior verification of fulfilment of the former.
which, as an Electronic Data Interchange (EDI), drives and The generalisation of this strategy shall entail a far-reaching
intervenes in the supply chain. transformation of both the management of goods and
the management of messages that drive their movement
• Management of goods. Traceability. through the supply chain, thereby resulting in considerable
The procedures incorporated into the functional improvements in the efficiency of the internal processes
design of this platform have been based on the full and a considerable reduction in the costs of management
implementation of the GS1 identification standard, of goods.
thereby completing the course of action described in
the preceding paragraphs. 6. Improving the efficiency of the logistics system:
This set of initiatives aims to improve the control and redesign strategies.
logistics management of the goods moving through the
supply chain, as well as their traceability. As has already been emphasised, the SIGLO® management
The automation of the process of receiving orders and platform must enable all its users to operate under the same
their validation, the elimination of errors and incidents operation model, given that its management procedures
during processing, the accurate knowledge of the are shared.
levels of stocks in storage, the correct preparation and
management of orders for restocking and distribution, This condition enables us to understand the Corporate
and the monitoring of consumption, among other Logistics System as a network in which each node (Centre),
factors, are benefits that are hoped to be obtained in which until now has functioned in an autonomous and
each of the Centres following the implementation of this unconnected manner, is integrated into a coordinated and
system, thereby considerably improving the efficiency interactive structure. This evolution is only possible with the
of certain processes that currently involve a significant establishment of a common “intelligence”, a logical system
administrative workload. In addition, we must consider which harmonises and coordinates the operation
the possibility of integrating resources so as to favour of all its nodes.
their shared use, given that the management tools and
the organisational bases are shared. We shall address this Irrespective of the direct improvements in the internal
matter in the final section. efficiency of each node that this entails, this measure enables
• Management of business messaging (EDI) us to establish a new analysis and redesign approach for the
The automation of the goods identification process Corporate Logistics System. We must not forget that a logistics
by means of the systematic use of bar codes must system currently exists for each Centre within this network.
be completed with the establishment of a standard
protocol of communication of business messages A significant reservoir of improvement initiatives therefore
between the agents involved in the logistics chain. exists for the global efficiency of the logistics system, which
The Andalusian Health Service has, as an initial step, must explore the standardisation and the shared use of
integrated the following into the functional structure logistics resources on the basis of an efficient
of the SIGLO® platform: use of the order messages distribution system.
(ORDER), delivery note (DESADV), confirmation of
reception (RECADV) and invoice (INVOIC), so that close We shall devote our attention to
monitoring can be established for each step as of the this issue in the future.
Authors
Jesus Gavira is Deputy Director of Purchasing and Logistics in Medicine and Surgery by the University of Seville, graduated
of the Andalusian Health Service. He is also a member of the in Public Health and health Administration by the Andalusian
Committee of the Sector Health of GS1 Spain and coordinates School of Public Health, and has a Master in Economy of the
the activities of the Technical Commission of Purchases and Health and Sanitary Management by the Central Universities and
Logistics of the National Health System. Mr. Gavira holds a degree Pompeu Fabra of Barcelona.
www.gs1.org